期刊文献+

鱼类过敏原缓释微球的制备及释放动力学的初步研究 被引量:1

Study on fish allergen microcapsules and controlled-release kinetics
下载PDF
导出
摘要 为制备一种能够缓慢释放的鱼类过敏原——小清蛋白的海藻酸钠微球,采用离子凝胶法制备出形态完好的海藻酸钠-小清蛋白微球,利用傅里叶红外光谱、差式扫描量热法、扫描电子显微镜等对其结构进行表征,并初步探究微球中小清蛋白在模拟肠液pH环境中的释放动力学参数。测得海藻酸钠对小清蛋白的包埋率为69.24%,蛋白装载率为21.06%,微球表面粗糙并分布有大量的微小孔洞,体外释放实验测得前5 h小清蛋白释放迅速,而后逐渐达到最大值,其释放动力学符合Higuchi模型和Ritger-Peppas模型。结果表明,海藻酸钠可以作为包埋小清蛋白的载体并实现小清蛋白的缓慢释放,其释放机理符合骨架溶蚀蛋白扩散机制。 The aim is to prepare a kind of sodium alginate microcapsules which could slowly release fish allergens. The spherical alginate microcapsules were prepared by the ionotropic gelation method and the microcapsules were formed by adding sodium alginate into aqueous solution containing calcium chloride. The prepared microcapsules were characterized by FTIR, DSC and SEM methods. The releasing mechanism of parvalbumin from the microcapsules was established based on equation fitting of release kinetics model. Parvalbumin could be embedded into alginate microcapsules. The entrapment efficiency was 69.24% while the loading ratio was 21.06%. The surface of microcapsules which had plenty of tiny holes was rough. The result of protein release in vitro showed that parvalbumin released rapidly in the first 5 hours, and then gradually achieved maximum. The release kinetics model suited Higuchi equation and Ritger-Peppas equation well. Fish allergen could be entrapped by sodium alginate, meanwhile allergen controlled-release was achieved. The mechanism fits with skeleton erosion in addition to protein diffusion mechanism.
出处 《水产学报》 CAS CSCD 北大核心 2012年第11期1748-1753,共6页 Journal of Fisheries of China
基金 现代农业产业技术体系建设专项(CARS-50) 长江学者和创新团队发展计划项目
关键词 过敏原 海藻酸钠 缓释 动力学 allergen sodium alginate controlled-release kinetics
  • 相关文献

参考文献23

  • 1Green T, Burks A. Oral food desensitization[J]. Current Allergy and Asthma Reports, 2010, 10(6): 391-397.
  • 2陈云,罗丽花,周紫燕,黄进.海藻酸钠/大豆蛋白共混凝胶微球的结构[J].武汉大学学报(理学版),2006,52(4):396-400. 被引量:15
  • 3Zhang Y, Jia X, Wang L,et al. Preparation of ca-alginate microparticles and its application for phenylketonuria oral therapy[J]. Industrial & Engineering Chemistry Research, 2011, 50(7): 4106-4112.
  • 4Zhang Y, Wei W, Lv P, et al. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin[J]. European Journal of Pharmaceutics and Biopharmaceutics, 201 1, 77(1): 11-19.
  • 5Beale J E, Jeebhay M F, Lopata A L. Characterisation of purified parvalbnmin from five fish s!6ecies and nucleotide sequencing of this major allergen from Pacific pilchard, Sardinops sagax[J]. Molecular Immu- nology, 2009, 46(15): 2985-2993.
  • 6Arif S H, Jabeen M, Hasnain A. Biochemical characterization and thermostable capacity of parval- bumins: the majior fish-food allergens[J]. Journal of Food Biochemistry, 2007, 31(1): 121-137.
  • 7Swoboda I, Bugajska-Schretter A, Verdino P, et al. Recombinant carp parvalbumin, the major cross-reactive fish allergen: a tool for diagnosis and therapy of fish allergy[J]. Journal of Immunology, 2002, 168(9): 4576- 4584.
  • 8吴玟静,李振兴,金科,郑礼娜,王邦平,林洪.青岛地区常见鱼类过敏原的鉴定及其交叉反应研究[J].水产学报,2011,35(10):1532-1539. 被引量:5
  • 9Van Do T, Hordvik I, Endresen C, et al. Characteri- zation of parvalbumin, the major allergen in alaska pollack, and comparison with codfish allergen m[J]. Molecular Immunology, 2005, 42(3): 345-353.
  • 10Li S, Wang X, Zhang X, et al. Studies on alginate- chitosan microcapsules and renal arterial embolization in rabbits[J]. Journal of Controlled Release, 2002, 84(3): 87-98.

二级参考文献100

共引文献86

同被引文献20

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部